Cellular Biomedicine Group, Inc.
CBMG
CBMG was delisted on the 19th of February, 2021.
38 hedge funds and large institutions have $16.3M invested in Cellular Biomedicine Group, Inc. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 10 closing their positions.
90% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 10
16% less funds holding
Funds holding: 45 → 38 (-7)
46% less capital invested
Capital invested by funds: $30.3M → $16.3M (-$13.9M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$2.13M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.14M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.09M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$595K |
| 5 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$388K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$808K |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$514K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$472K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$375K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$293K |
CBMG Hedge Fund Activity: Q3 2015 in Review
38 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Cellular Biomedicine Group, Inc. (CBMG) for Q3 2015, worth a combined $16.3M — down 46% from $30.3M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CBMG and 3 opened new positions — a net loss of 7 holders — while 10 trimmed existing stakes and 19 added.
The largest buyer was Northern Trust, adding an estimated $2.13M. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $808K sold.
- 38 institutional investors held Cellular Biomedicine Group, Inc. (CBMG) as of Q3 2015, down from 45 in Q2 2015.
- Funds reported $16.3M of Cellular Biomedicine Group, Inc. stock for Q3 2015, down 46% quarter-over-quarter.
- 3 funds opened new Cellular Biomedicine Group, Inc. positions in Q3 2015 and 10 closed out, a net change of -7 holders.
- The largest Cellular Biomedicine Group, Inc. buyer in Q3 2015 was Northern Trust, an estimated $2.13M added.
- The largest Cellular Biomedicine Group, Inc. seller in Q3 2015 was A.R.T. Advisors, an estimated $808K sold.
Based on aggregated 13F filings for Q3 2015.